These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Proceedings of the 18th Annual Optic Nerve Rescue and Restoration Think Tank: "Glaucoma and the Central Nervous System" September 16-17, 2011 New York, NY, sponsored by The Glaucoma Foundation (TGF). Introduction. Park SC J Glaucoma; 2013; 22 Suppl 5():S1. PubMed ID: 23733113 [No Abstract] [Full Text] [Related]
7. [Characteristics of the functional state of the central nervous system in the initial stage of glaucoma]. IGOSHINA NF Vestn Oftalmol; 1957; 70(6):11-7. PubMed ID: 13530567 [No Abstract] [Full Text] [Related]
8. [Higher nervous function tests in glaucoma]. PROTOPOPOV BV; DOBROTINA AN Vestn Oftalmol; 1954; 33(5):8-10. PubMed ID: 13217152 [No Abstract] [Full Text] [Related]
9. [Results of determination of type of the higher nervous function in glaucoma]. KHRISTOZOV Kh; UGLOVA T Suvr Med (Sofiia); 1954; 5(1):25-31. PubMed ID: 13178961 [No Abstract] [Full Text] [Related]
10. [Is glaucoma a central nervous system disease: re-evaluation]. Liu XY; Chen XM; Wang NL Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1062-5. PubMed ID: 21211216 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of pathogenetically oriented, conservative treatment in glaucoma as a general pathological process]. Eroshevskiĭ TI; Zatulina NI; Il'icheva TS Oftalmol Zh; 1981; 36(3):145-8. PubMed ID: 7024885 [No Abstract] [Full Text] [Related]
12. [Attempt to eliminate the effect of the central vegetative nervous system on glaucoma]. DIENSTBIER E; BALIK J Cesk Oftalmol; 1951; 7(3):163-9. PubMed ID: 14848877 [No Abstract] [Full Text] [Related]
13. Glaucoma as a neurodegenerative disease. Danesh-Meyer HV; Levin LA J Neuroophthalmol; 2015 Sep; 35 Suppl 1():S22-8. PubMed ID: 26274833 [TBL] [Abstract][Full Text] [Related]
14. [Similarity of the pathogenetic links of primary glaucoma and hypertension]. Zatulina NI; Il'icheva TS Oftalmol Zh; 1976; 31(8):608-11. PubMed ID: 799272 [No Abstract] [Full Text] [Related]
15. The central nervous influence of drugs on intraocular pressure. Innemee HC; van Zwieten PA Rev Pure Appl Pharmacol Sci; 1980; 1(2):107-65. PubMed ID: 6267661 [No Abstract] [Full Text] [Related]
16. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Madeira MH; Ortin-Martinez A; Nadal-Nícolas F; Ambrósio AF; Vidal-Sanz M; Agudo-Barriuso M; Santiago AR Sci Rep; 2016 Jun; 6():27532. PubMed ID: 27270337 [TBL] [Abstract][Full Text] [Related]
17. Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system. Nucci C; Martucci A; Cesareo M; Garaci F; Morrone LA; Russo R; Corasaniti MT; Bagetta G; Mancino R Prog Brain Res; 2015; 221():49-65. PubMed ID: 26518072 [TBL] [Abstract][Full Text] [Related]
18. [INTRAOCULAR HYPOTENSION ORIGINATING FROM THE CENTRAL NERVOUS SYSTEM]. BRAND I Szemeszet; 1963 Dec; 100():193-6. PubMed ID: 14102564 [No Abstract] [Full Text] [Related]
19. Brain involvement in glaucoma: advanced neuroimaging for understanding and monitoring a new target for therapy. Nucci C; Martucci A; Cesareo M; Mancino R; Russo R; Bagetta G; Cerulli L; Garaci FG Curr Opin Pharmacol; 2013 Feb; 13(1):128-33. PubMed ID: 22981808 [TBL] [Abstract][Full Text] [Related]
20. [Functional magnetic resonance imaging in glaucoma]. Chen ZQ; Gao J; Zhang H Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):1045-8. PubMed ID: 23302279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]